{
    "title": "GlaxoSmithKline hails major HIV breakthrough: Drugs giant claims injections better than daily pill",
    "url": "https://www.dailymail.co.uk/money/markets/article-8332605/GlaxoSmithKline-hails-major-HIV-breakthrough.html",
    "date": "2020-05-18",
    "keywords": [
        "drug",
        "injection",
        "hiv",
        "cent",
        "year",
        "treatment",
        "company",
        "study",
        "research",
        "gsk",
        "trial",
        "glaxosmithkline",
        "month",
        "pill",
        "boost",
        "emma",
        "walmsley",
        "market",
        "virus",
        "share",
        "coronavirus",
        "breakthrough",
        "ceo",
        "prioritythe",
        "lead",
        "glaxo",
        "sector",
        "gilead",
        "success",
        "executive",
        "respiratory",
        "oncology",
        "immuneinflammation",
        "viiv",
        "healthcare",
        "head",
        "longacting",
        "routine",
        "stigma",
        "smith",
        "injectable",
        "gamechanger",
        "prevention",
        "frequency",
        "clinic",
        "inbetween",
        "need",
        "equation",
        "adherence",
        "pharma",
        "rescue",
        "race",
        "vir",
        "biotechnology",
        "article",
        "transgender",
        "africa",
        "thailandthe",
        "period",
        "key",
        "spread",
        "disease",
        "sister",
        "pipeline",
        "combination",
        "chimpanzee",
        "blood",
        "wound",
        "epidemiologist",
        "university",
        "washington",
        "seattle",
        "world",
        "sanofi",
        "vaccine",
        "night",
        "crisis",
        "shell",
        "ftse",
        "capitalisation",
        "bluechip",
        "hikma"
    ],
    "category": [
        "money",
        "markets"
    ]
}